Royalty Pharma plc
DE ˙ MUN ˙ GB00BMVP7Y09
46,92 € ↑0,92 (2,01%)
2026-06-04
AKTIENPREIS
SecurityDE:RPD / Royalty Pharma plc
InstitutionMacquarie Group Ltd
Latest Disclosed Ownership47,022 shares
Latest Disclosed Value $ 2,255,645
Macquarie Group Ltd reports 34.62% decrease in ownership of RPD / Royalty Pharma plc

On May 15, 2026 - Macquarie Group Ltd filed a 13F-HR form disclosing ownership of 47,022 shares of Royalty Pharma plc (DE:RPD) valued at $1,884,172 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 13, 2026 disclosing 71,925 shares of Royalty Pharma plc. This represents a change in shares of -34.62% during the quarter. The current value of the position is $2,206,507 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F ROYALTY PHARMA SHS CLASS A G7709Q104 47,022 -24,903 -34.62 2,256 -18.86 0.0105
2026-02-13 2025-12-31 13F ROYALTY PHARMA SHS CLASS A G7709Q104 71,925 18,677 35.08 2,779 47.98 0.0121
2025-11-13 2025-09-30 13F ROYALTY PHARMA SHS CLASS A G7709Q104 53,248 -15,921 -23.02 1,879 -24.64 0.0022
2025-08-14 2025-06-30 13F ROYALTY PHARMA SHS CLASS A G7709Q104 69,169 0 0.00 2,492 15.75 0.0031
2025-08-14 2025-03-31 13F/A-1 ROYALTY PHARMA SHS CLASS A G7709Q104 69,169 23,021 49.89 2,153 82.92 0.0027
2025-05-15 2025-03-31 13F ROYALTY PHARMA SHS CLASS A G7709Q104 69,169 23,021 2,153 0.0018
2025-02-14 2024-12-31 13F ROYALTY PHARMA SHS CLASS A G7709Q104 46,148 -640 -1.37 1,177 -11.04 0.0014
2024-11-14 2024-09-30 13F ROYALTY PHARMA SHS CLASS A G7709Q104 46,788 0 0.00 1,324 7.30 0.0014
2024-08-09 2024-06-30 13F ROYALTY PHARMA SHS CLASS A G7709Q104 46,788 1,062 2.32 1,234 -11.17 0.0014
2024-05-14 2024-03-31 13F ROYALTY PHARMA SHS CLASS A G7709Q104 45,726 0 0.00 1,389 8.10 0.0016
2024-02-14 2023-12-31 13F ROYALTY PHARMA SHS CLASS A G7709Q104 45,726 9,217 25.25 1,284 29.70 0.0015
2023-11-14 2023-09-30 13F ROYALTY PHARMA SHS CLASS A G7709Q104 36,509 18,304 100.54 991 77.10 0.0012
2023-10-27 2023-06-30 13F/A-2 ROYALTY PHARMA SHS CLASS A G7709Q104 18,205 8,982 97.39 560 68.37 0.0006
2023-10-12 2023-06-30 13F/A-1 ROYALTY PHARMA SHS CLASS A G7709Q104 18,205 8,982 560 0.0006
2023-08-14 2023-06-30 13F ROYALTY PHARMA SHS CLASS A G7709Q104 18,205 8,982 560 0.0006
2023-06-01 2023-03-31 13F/A-1 ROYALTY PHARMA SHS CLASS A G7709Q104 9,223 0 0.00 332 -8.79 0.0004
2023-05-15 2023-03-31 13F ROYALTY PHARMA SHS CLASS A G7709Q104 9,223 0 332 0.0003
2023-02-21 2022-12-31 13F ROYALTY PHARMA SHS CLASS A G7709Q104 9,223 2,145 30.31 364 27.72 0.0004
2022-11-14 2022-09-30 13F ROYALTY PHARMA SHS CLASS A G7709Q104 7,078 2,447 52.84 285 46.15 0.0003
2022-08-17 2022-06-30 13F/A-1 ROYALTY PHARMA SHS CLASS A G7709Q104 4,631 0 0.00 195 8.33 0.0002
2022-08-15 2022-06-30 13F ROYALTY PHARMA SHS CLASS A G7709Q104 4,631 0 195 0.0001
2022-05-16 2022-03-31 13F ROYALTY PHARMA SHS CLASS A G7709Q104 4,631 1,930 71.46 180 68.22 0.0001
2022-02-11 2021-12-31 13F ROYALTY PHARMA SHS CLASS A G7709Q104 2,701 -2,380 -46.84 107 -41.85 0.0001
2021-11-12 2021-09-30 13F ROYALTY PHARMA SHS CLASS A G7709Q104 5,081 0 0.00 184 -11.96 0.0002
2021-08-13 2021-06-30 13F ROYALTY PHARMA SH CLASS A G7709Q104 5,081 137 2.77 209 -3.24 0.0002
2021-05-14 2021-03-31 13F ROYALTY PHARMA SHS CLASS A G7709Q104 4,944 2,944 147.20 216 116.00 0.0003
2021-02-16 2020-12-31 13F ROYALTY PHARMA SHS CLASS A G7709Q104 2,000 2,000 100 0.0001
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.